Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Prostate. 2008 Sep 15;68(13):1467–1476. doi: 10.1002/pros.20812

Figure 3.

Figure 3

Box plots for M/E ratio assessed via IHC and stratified by pathologic stage and location of intratumoral staining. A) M/E ratio measured at the tumor edge (P = 0.0005 for M/E ratio > pT2 significantly higher than pT2 prostate cancers). B) M/E ratio measured at the tumor center (P = 0.98 M/E ratio not significantly different by pathologic stage at tumor center).